Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Sponsor: EP Plus Group Sdn Bhd
Summary
The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.
Official title: A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-10-17
Completion Date
2025-11-30
Last Updated
2024-11-08
Healthy Volunteers
No
Conditions
Interventions
Skal Pro
One sachet Skal Pro per day containing Lactobacillus plantarum 299v 1x10\^10 CFU and GOS
Placebo
One sachet per day identical in shape, size, colour, packaging and taste to the Skal Pro sachet
Locations (1)
Hospital Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia